These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


361 related items for PubMed ID: 20164327

  • 1. Neuronal nitric oxide synthase alteration accounts for the role of 5-HT1A receptor in modulating anxiety-related behaviors.
    Zhang J, Huang XY, Ye ML, Luo CX, Wu HY, Hu Y, Zhou QG, Wu DL, Zhu LJ, Zhu DY.
    J Neurosci; 2010 Feb 17; 30(7):2433-41. PubMed ID: 20164327
    [Abstract] [Full Text] [Related]

  • 2. Extracellular regulated protein kinaseis critical for the role of 5-HT1a receptor in modulating nNOS expression and anxiety-related behaviors.
    Cai CY, Wu HY, Luo CX, Zhu DY, Zhang Y, Zhou QG, Zhang J.
    Behav Brain Res; 2019 Jan 14; 357-358():88-97. PubMed ID: 29246772
    [Abstract] [Full Text] [Related]

  • 3. Loss of Adult 5-HT1A Autoreceptors Results in a Paradoxical Anxiogenic Response to Antidepressant Treatment.
    Turcotte-Cardin V, Vahid-Ansari F, Luckhart C, Daigle M, Geddes SD, Tanaka KF, Hen R, James J, Merali Z, Béïque JC, Albert PR.
    J Neurosci; 2019 Feb 20; 39(8):1334-1346. PubMed ID: 30552180
    [Abstract] [Full Text] [Related]

  • 4. Regulator of G-protein signaling 6 (RGS6) promotes anxiety and depression by attenuating serotonin-mediated activation of the 5-HT(1A) receptor-adenylyl cyclase axis.
    Stewart A, Maity B, Wunsch AM, Meng F, Wu Q, Wemmie JA, Fisher RA.
    FASEB J; 2014 Apr 20; 28(4):1735-44. PubMed ID: 24421401
    [Abstract] [Full Text] [Related]

  • 5. 5-HT1A receptors are differentially involved in the anxiolytic- and antidepressant-like effects of 8-OH-DPAT and fluoxetine in the rat.
    De Vry J, Schreiber R, Melon C, Dalmus M, Jentzsch KR.
    Eur Neuropsychopharmacol; 2004 Dec 20; 14(6):487-95. PubMed ID: 15589388
    [Abstract] [Full Text] [Related]

  • 6. Requirement of hippocampal DG nNOS-CAPON dissociation for the anxiolytic and antidepressant effects of fluoxetine.
    Shi HJ, Wu DL, Chen R, Li N, Zhu LJ.
    Theranostics; 2022 Dec 20; 12(8):3656-3675. PubMed ID: 35664081
    [Abstract] [Full Text] [Related]

  • 7. Rapid desensitization of 5-HT(1A) receptors in Fawn-Hooded rats after chronic fluoxetine treatment.
    Kantor S, Graf M, Anheuer ZE, Bagdy G.
    Eur Neuropsychopharmacol; 2001 Feb 20; 11(1):15-24. PubMed ID: 11226808
    [Abstract] [Full Text] [Related]

  • 8. 5HT(1A) and 5HT(1B) receptors of medial prefrontal cortex modulate anxiogenic-like behaviors in rats.
    Solati J, Salari AA, Bakhtiari A.
    Neurosci Lett; 2011 Oct 31; 504(3):325-9. PubMed ID: 21982809
    [Abstract] [Full Text] [Related]

  • 9. 5-HT1A and 5-HT7 receptor crosstalk in the regulation of emotional memory: implications for effects of selective serotonin reuptake inhibitors.
    Eriksson TM, Holst S, Stan TL, Hager T, Sjögren B, Ogren SÖ, Svenningsson P, Stiedl O.
    Neuropharmacology; 2012 Nov 31; 63(6):1150-60. PubMed ID: 22801295
    [Abstract] [Full Text] [Related]

  • 10. The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats. A comparison with other anxiolytic agents.
    Dekeyne A, Brocco M, Adhumeau A, Gobert A, Millan MJ.
    Psychopharmacology (Berl); 2000 Sep 31; 152(1):55-66. PubMed ID: 11041316
    [Abstract] [Full Text] [Related]

  • 11. Roles of 5-HT(1A) receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model.
    Cervo L, Mocaër E, Bertaglia A, Samanin R.
    Neuropharmacology; 2000 Apr 03; 39(6):1037-43. PubMed ID: 10727714
    [Abstract] [Full Text] [Related]

  • 12. Role of 5-HT(1A) receptors in fluoxetine-induced lordosis inhibition.
    Guptarak J, Sarkar J, Hiegel C, Uphouse L.
    Horm Behav; 2010 Jul 03; 58(2):290-6. PubMed ID: 20223238
    [Abstract] [Full Text] [Related]

  • 13. Mice deficient in the alpha subunit of G(z) show changes in pre-pulse inhibition, anxiety and responses to 5-HT(1A) receptor stimulation, which are strongly dependent on the genetic background.
    van den Buuse M, Martin S, Holgate J, Matthaei K, Hendry I.
    Psychopharmacology (Berl); 2007 Dec 03; 195(2):273-83. PubMed ID: 17684732
    [Abstract] [Full Text] [Related]

  • 14. On the elevated plus-maze the anxiolytic-like effects of the 5-HT(1A) agonist, 8-OH-DPAT, but not the anxiogenic-like effects of the 5-HT(1A) partial agonist, buspirone, are blocked by the 5-HT1A antagonist, WAY 100635.
    Collinson N, Dawson GR.
    Psychopharmacology (Berl); 1997 Jul 03; 132(1):35-43. PubMed ID: 9272757
    [Abstract] [Full Text] [Related]

  • 15. Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test.
    Zhang H, Wang W, Jiang Z, Shang J, Zhang L.
    Arzneimittelforschung; 2010 Jul 03; 60(3):109-15. PubMed ID: 20422941
    [Abstract] [Full Text] [Related]

  • 16. Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects.
    Bortolozzi A, Castañé A, Semakova J, Santana N, Alvarado G, Cortés R, Ferrés-Coy A, Fernández G, Carmona MC, Toth M, Perales JC, Montefeltro A, Artigas F.
    Mol Psychiatry; 2012 Jun 03; 17(6):612-23. PubMed ID: 21808255
    [Abstract] [Full Text] [Related]

  • 17. Serotonergic control of ingestive and post-ingestive behaviors in pigeons (Columba livia): the role of 5-HT1A receptor-mediated central mechanisms.
    Hoeller AA, Dos Santos TS, Bruxel RR, Dallazen AR, do Amaral Silva HT, André ES, Marino-Neto J.
    Behav Brain Res; 2013 Jan 01; 236(1):118-130. PubMed ID: 22954717
    [Abstract] [Full Text] [Related]

  • 18. Testosterone promotes anxiolytic-like behavior in gonadectomized male rats via blockade of the 5-HT1A receptors.
    Fedotova J, Hritcu L.
    Gen Comp Endocrinol; 2017 Dec 01; 254():14-21. PubMed ID: 28919453
    [Abstract] [Full Text] [Related]

  • 19. Behavioral and neurochemical effects of 5-(4-[4-(5-Cyano-3-indolyl)-butyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide (EMD 68843): a combined selective inhibitor of serotonin reuptake and 5-hydroxytryptamine(1A) receptor partial agonist.
    Page ME, Cryan JF, Sullivan A, Dalvi A, Saucy B, Manning DR, Lucki I.
    J Pharmacol Exp Ther; 2002 Sep 01; 302(3):1220-7. PubMed ID: 12183683
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats.
    Wesołowska A, Paluchowska MH, Gołembiowska K, Chojnacka-Wójcik E.
    J Pharm Pharmacol; 2003 Apr 01; 55(4):533-43. PubMed ID: 12803776
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 19.